Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 – Biotech Investments
Rancho Cucamonga, 05/08/2024 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for